The FDA studies were fixed and flawed. Also, BioElectronics didn't come close to winning the FDA Opioid Challenge. The device barely squeaked by the fixed and flawed studies.
The FDA should have saved BIEL'S investors the pain and cleared it in 2008-9 since the device is totally worthless like ActiBand was.
But, with that said, consumers will find out soon enough the device is useless 95% of the time.
Yes sir srin...and Biel's new OEM partners obviously like the ability to sell pain diminishing PEMF over the counter. If you want to sell the stuff OTC...you'll just have to do business with Biel. It's a beautiful monopoly for Biel to have. Investors take note...Biel has a monopoly...and a legal one that! Go Biel!